Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Advanced-J Japan Heart Foundation |
---|---|
Information provided by: | Advanced-J |
ClinicalTrials.gov Identifier: | NCT00144144 |
The antihypertensive effect of the increased dose of angiotensin II receptor blocker (AII antagonist) is compared with that of the additional combined use of amlodipine in hypertensive patients with Type 2 diabetes mellitus, who have been treated with AII antagonist, the antihypertensive effect of which has been inadequate.
Condition | Intervention | Phase |
---|---|---|
Hypertension Diabetes Mellitus, Type 2 |
Drug: Angiotensin II receptor antagonists, Calcium channel blocker |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Controlled Study on Calcium Channel Blocker Versus Angiotensin II Antagonists in the Hypertensive Patients With Type 2 Diabetes Mellitus Under the Inadequately Controlled Blood Pressure With Angiotension II Antagonists |
Estimated Enrollment: | 300 |
Study Start Date: | September 2004 |
Estimated Study Completion Date: | September 2008 |
Ages Eligible for Study: | 20 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Japan, Tokyo | |
Dept. of Clinical Immunology, Clinical Bioinformatics Research Unit, Graduate School of Medicine, the University of Tokyo | |
Hongo, Bunkyo-ku, Tokyo, Japan, 113-8655 |
Principal Investigator: | Ryuzo Kawamori, M.D. | Juntendo University School of Medicine, Dept. of Endocrinology and Metabolism |
Study ID Numbers: | ADVANCED-J01, UMIN-C000000017 |
Study First Received: | September 1, 2005 |
Last Updated: | July 13, 2006 |
ClinicalTrials.gov Identifier: | NCT00144144 |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Hypertension Diabetes Mellitus, Type 2 Calcium Channel Blocker Angiotensin II type 1 Receptor Blocker |
Calcium, Dietary Metabolic Diseases Diabetes Mellitus, Type 2 Vascular Diseases Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Angiotensin II Metabolic disorder Glucose Metabolism Disorders Hypertension |
Therapeutic Uses Vasoconstrictor Agents Cardiovascular Diseases Cardiovascular Agents Pharmacologic Actions |